Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1500 of 2873 entries
View as:

Proton Therapy and Bevacizumab for Primary Liver Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00426829 Org: User:
Start: 05/31/07 End: 11/30/09 Due: 11/30/10

Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01701986 Org: User:
Start: 10/25/12 End: 06/05/24 Due: 06/05/25

Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02397083 Org: User:
Start: 09/23/15 End: 09/30/26 Due: 09/30/27

Your Health Matters! (Tu Salud ¡Si Cuenta!): Promoting Healthy Lifestyles in Latino Families

Phase: N/A Priority: Normal
NCT ID: NCT03199209 Org: User:
Start: 06/06/16 End: 12/31/25 Due: 12/31/26

LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02652871 Org: User:
Start: 05/09/16 End: 07/16/19 Due: 07/16/20

Mind-Body Intervention in Glioma Couples

Phase: N/A Priority: Normal
NCT ID: NCT03244995 Org: User:
Start: 08/06/17 End: 12/31/25 Due: 12/31/26

Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis

Phase: N/A Priority: Normal
NCT ID: NCT01295645 Org: User:
Start: 03/17/11 End: 03/15/26 Due: 03/15/27

Glutamine PET Imaging Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03275974 Org: User:
Start: 04/27/21 End: 05/31/25 Due: 05/31/26

STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain

Phase: N/A Priority: Normal
NCT ID: NCT01904123 Org: User:
Start: 07/13/18 End: 03/16/22 Due: 03/16/23

Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00502411 Org: User:
Start: 01/31/03 End: 04/30/15 Due: 04/30/16

Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT04743466 Org: User:
Start: 02/13/20 End: 11/30/25 Due: 11/30/26

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01636934 Org: User:
Start: 07/31/12 End: 09/23/19 Due: 09/23/20

Hepatic Arterial Infusion (HAI) of Abraxane

Phase: N/A Priority: Normal
NCT ID: NCT00732836 Org: User:
Start: 06/30/08 End: 01/31/16 Due: 01/31/17

A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

Phase: N/A Priority: Normal
NCT ID: NCT06597734 Org: User:
Start: 01/28/25 End: 08/31/29 Due: 08/31/30

Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04985565 Org: User:
Start: 08/27/21 End: 10/20/25 Due: 10/20/26

TAS-102 in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05343013 Org: User:
Start: 06/06/22 End: 05/15/27 Due: 05/15/28

Gleevec Study for Patients With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00510653 Org: User:
Start: 03/31/02 End: 02/29/12 Due: 02/28/13

Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00063258 Org: User:
Start: 06/30/03 End: 04/30/08 Due: 04/30/09

Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00745134 Org: User:
Start: 08/11/08 End: 11/11/22 Due: 11/11/23

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

Phase: N/A Priority: Normal
NCT ID: NCT06566742 Org: User:
Start: 12/10/24 End: 08/31/29 Due: 08/31/30

Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00791635 Org: User:
Start: 07/11/08 End: 09/30/25 Due: 09/30/26

A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05672459 Org: User:
Start: 06/21/23 End: 12/29/29 Due: 12/29/30

High-Intensity Interval Training for Women at Heightened Risk for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02923401 Org: User:
Start: 09/30/16 End: 01/05/22 Due: 01/05/23

A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05497778 Org: User:
Start: 10/21/22 End: 02/02/27 Due: 02/02/28

Understanding Patient's Knowledge and Use of Acetaminophen

Phase: N/A Priority: Normal
NCT ID: NCT00823758 Org: User:
Start: 12/19/08 End: 12/01/20 Due: 12/01/21